Ashly Hindle

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma

Balakrishna Koneru, Gonzalo López, Ahsan Farooqi et al. · Cancer Research · 2020 · 100 citations · Full text

Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High <i>SLFN11</i> Expression

Min H. Kang, Jing Wang, Monish Ram Makena et al. · Clinical Cancer Research · 2015 · 97 citations · Full text

ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156

Balakrishna Koneru, Ahsan Farooqi, Thinh H. Nguyen et al. · Science Translational Medicine · 2021 · 57 citations · Full text

A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease

Sudhir Kshirsagar, Rainier Vladlen Alvir, Jangampalli Adi Pradeepkiran et al. · Cells · 2022 · 38 citations · Full text

Mitophagy, Mitochondrial Dysfunction, Neurochemical Biomarkers +27

MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma

Sung‐Jen Wei, Thinh H. Nguyen, In‐Hyoung Yang et al. · Cell Death and Disease · 2020 · 32 citations · Full text